Research
Excludes commercial-in-confidence projects.
Characterising an RNA splicing pathway driving prostate cancer metastasis and therapy resistance, NHMRC - Project Grant, 01/01/2019 - 31/12/2022
Discovering how microRNAs and circRNAs control cancer metastasis, NHMRC - Research Fellowship, 01/01/2017 - 31/12/2021
Use of a new molecule (miR-342) to discover important pathways to treat advanced breast cancer, NBCF - Investigator Initiated Research Scheme, 01/01/2018 - 01/07/2021
Develop efficient data mining methods for evidence based decision making, ARC - Discovery Projects, 29/06/2017 - 28/06/2021
Using miR-200 to find new therapeutic targets for neuroblastoma, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Characterising novel alternative splicing networks that promote tumour cell plasticity, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Functions of circular RNAs, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Cancer Discovery Accelerator, Australian Cancer Research Foundation, 01/06/2016 - 31/07/2018
Role of the microRNA target Quaking in alternative splicing during EMT and cancer progression, NHMRC - Project Grant, 01/01/2014 - 31/12/2017
Targeting microRNA-driven mesenchymal to epithelial transition to suppress prostate cancer metastasis, NHMRC - Project Grant, 01/01/2015 - 31/12/2017
Do circular RNAs affect breast cancer progression?, National Breast Cancer Foundation - Innovator Grant, 01/01/2016 - 31/12/2017
Formation and function of circular RNAs in human cells, NHMRC - Project Grant, 01/01/2015 - 31/12/2017
Cancer Discovery Accelerator, Cancer Council SA - Beat Cancer, 08/06/2016 - 08/06/2017
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID
Open access indicates that an output is open access.
Year | Output |
---|---|
2024 |
Open access
4
4
|
2024 |
Open access
5
6
2
|
2024 |
1
1
|
2024 |
Open access
2
|
2024 |
Open access
5
4
1
|
2024 |
26
23
116
|
2023 |
33
31
268
|
2023 |
Open access
5
5
18
|
2023 |
Open access
1
1
2
|
2023 |
Open access
6
6
4
|
2022 |
45
43
10
|
2022 |
Open access
26
22
71
|
2022 |
Open access
22
22
1
|
2021 |
Open access
33
34
120
|
2021 |
Goodall, GJ & Wickramasinghe, VO 2021, 'RNA in cancer', Nature Reviews Cancer, vol. 21, pp. 22-36.
Open access
762
744
|
2021 |
Open access
15
15
|
2021 |
Open access
9
7
|
2021 |
Open access
19
18
8
|
2021 |
Open access
12
11
2
|
2020 |
Open access
6
7
1
|
2020 |
Open access
9
9
|
2020 |
Open access
11
9
9
|
2020 |
Open access
1265
1213
|
2019 |
Open access
23
22
5
|
2019 |
Open access
14
14
1
|
2019 |
Open access
6
5
5
|
2019 |
14
16
1
|
2019 |
Open access
107
101
|
2018 |
Open access
116
115
|
2018 |
Open access
19
|
2018 |
Open access
72
67
28
|
2018 |
Open access
29
26
2
|
2018 |
Open access
21
19
1
|
2018 |
Open access
84
83
15
|
2018 |
Open access
40
36
|
2017 |
Open access
97
98
57
|
2017 |
44
43
|
2017 |
Open access
91
89
11
|
2017 |
Open access
58
55
7
|
2016 |
Open access
577
551
33
|
2015 |
53
52
19
|
2015 |
Open access
50
50
1
|
2015 |
Open access
1668
1626
23
|
2015 |
Open access
34
32
|
2015 |
Open access
30
28
|
2015 |
Open access
45
46
|
2015 |
Open access
33
30
2
|
2015 |
Open access
59
55
5
|
2014 |
Open access
54
56
|
2014 |
Open access
123
120
13
|
2014 |
54
51
|
2014 |
Open access
60
57
|
2014 |
Open access
25
24
|
2014 |
43
59
|
2014 |
32
32
10
|
2014 |
Open access
21
18
3
|
2013 |
Open access
20
18
|
2013 |
Open access
171
155
|
2013 |
Open access
152
140
|
2013 |
Open access
146
137
|
2013 |
Open access
104
102
|
2012 |
Open access
139
137
|
2012 |
Open access
91
84
|
2012 |
383
360
|
2011 |
Open access
69
66
|
2011 |
Open access
492
466
|
2011 |
Open access
128
121
|
2011 |
Open access
471
441
|
2011 |
Open access
177
164
|
2010 |
99
97
|
2010 |
Open access
76
65
|
2010 |
Open access
120
117
|
2010 |
Open access
88
76
|
2009 |
107
96
|
2009 |
32
30
|
2009 |
Open access
438
416
|
2009 |
53
51
|
2008 |
Open access
931
879
|
2008 |
Open access
438
405
|
2008 |
Open access
76
72
|
2008 |
3375
3179
|
External engagement & recognition
Organisation | Country |
---|---|
Australian National University | AUSTRALIA |
Bar-Ilan University | ISRAEL |
Baylor College of Medicine | UNITED STATES |
Canberra Hospital | AUSTRALIA |
Cancer Council of South Australia | AUSTRALIA |
Central Queensland University | AUSTRALIA |
Charles Sturt University | AUSTRALIA |
Children's Cancer Institute Australia | AUSTRALIA |
Childrens Hospital at Westmead | AUSTRALIA |
Dali University | CHINA |
Deakin University | AUSTRALIA |
Flinders University | AUSTRALIA |
Friedrich Miescher Institute for Biomedical Research | SWITZERLAND |
Garvan Institute of Medical Research | AUSTRALIA |
Ghent University | BELGIUM |
Hanson Institute | AUSTRALIA |
Harvard University | UNITED STATES |
Hudson Institute of Medical Research | AUSTRALIA |
Institute of Medical and Veterinary Science | AUSTRALIA |
Istituto di Ricerche Farmacologiche Mario Negri | ITALY |
Kanazawa University | JAPAN |
Kumamoto University | JAPAN |
Kunming University of Science and Technology | CHINA |
Mahidol University | THAILAND |
Memorial Sloan Kettering Cancer Centre | UNITED STATES |
Monash University | AUSTRALIA |
Monterrey Institute Of Technology And Higher Education | MEXICO |
Mount Sinai Hospital | UNITED STATES |
Nagasaki University | JAPAN |
National University of Singapore | SINGAPORE |
Peter MacCallum Cancer Centre | AUSTRALIA |
QIMR Berghofer Medical Research Institut | AUSTRALIA |
Queensland University of Technology | AUSTRALIA |
Royal Brisbane and Women's Hospital | AUSTRALIA |
Royal Children's Hospital | UNITED KINGDOM |
SA Pathology | AUSTRALIA |
Shanghai Jiao Tong University | CHINA |
South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
St Vincent's Hospital | AUSTRALIA |
St. Vincent's Institute of Medical Research | AUSTRALIA |
Stanford University | UNITED STATES |
Sun Yat-Sen University | CHINA |
The Institut Pasteur | FRANCE |
The Queen Elizabeth Hospital | AUSTRALIA |
University Health Network | CANADA |
University Libre Bruxelles | BELGIUM |
University of Adelaide | AUSTRALIA |
University of Arizona | UNITED STATES |
University of Basel | SWITZERLAND |
University of Bonn | GERMANY |
University of British Columbia | CANADA |
University of California | UNITED STATES |
University of California San Diego | UNITED STATES |
University of Canberra | AUSTRALIA |
University of Laval | CANADA |
University of Malaya | MALAYSIA |
University of Melbourne | AUSTRALIA |
University of New South Wales | AUSTRALIA |
University of Newcastle | AUSTRALIA |
University of North Carolina at Chapel Hill | UNITED STATES |
University Of Oklahoma Norman | UNITED STATES |
University of Pennsylvania | UNITED STATES |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of Surrey | UNITED KINGDOM |
University of Sydney | AUSTRALIA |
University of Texas | UNITED STATES |
University of Texas MD Anderson Cancer Centre | UNITED STATES |
University of Toronto | CANADA |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
FellowAustralian Academy of Science |
2018 |
Julian Wells MedalLorne Genome Conference |
2018 |
Project GrantNational Health and Medical Research Council (NHMRC) |
2016 |
FellowAustralian Academy of Health and Medical Science |
2015 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
110391 - Oncogenic drivers of neuroblastoma | Current |
110423 - Tackling Neuroblastoma using a multi-omics bioinformatics approach | Current |
111069 - Illuminating the function of alternative splicing in cancer using CRISPR-based screens | Current |
A novel protein ZCCHC24 as a regulator of breast cancer cell plasticity and metastasis | Current |
Alternative splicing networks and their impact on the development of aggressive prostate cancer | Current |
Nuclear functions of microRNAs that control EMT in breast cancer | Current |
Targeting oncogenic signalling with custom RNA drugs | Current |
Understanding how the epigenetic field effect exerted by cancers upon their microenvironment promotes tumour progression | Current |
Understanding how the epigenetic field effect exerted by cancers upon their microenvironment promotes tumour progression | Current |
Computational modelling for breast cancer prognosis in precision medicine | Completed |
Developing network inference methods for cancer driver discovery | Completed |
Elucidating coding region targets of microRNAs | Completed |
The role of RNA-binding proteins in epithelial-mesenchymal transition | Completed |